Navigation Links
Clinlogix Strengthens Partnership With eClinical Technology Leader MedNet Solutions
Date:12/8/2015

MINNETONKA, Minn., Dec. 8, 2015 /PRNewswire/ -- MedNet Solutions, a global life sciences technology company specializing in clinical study management solutions, is pleased to announce that Clinlogix, a leading international Clinical Research Organization (CRO), will expand its existing relationship with MedNet by joining the iMedNet Partner Program and increasing its utilization of iMedNet eClinical.  As Clinlogix experiences increased demand for its CRO services, iMedNet will play an even stronger role in helping the firm provide the most efficient and cost-effective management and oversight of clinical research studies.

"Clinlogix is excited to further its relationship with MedNet Solutions, especially given their level of extreme attentiveness, customer service and flexibility as an organization," said JeanMarie Markham, CEO of Clinlogix. "The iMedNet platform provides the workflows and functionality needed – in an intuitive format – that are so critical in helping our customers bring their technologies to the marketplace in the most effective manner possible."

iMedNet is a comprehensive, flexible and award-winning eClinical technology platform designed to maximize clinical study efficiency. The platform has proven to be a vital toolset for many CROs – including Clinlogix – in study management, meeting clinical study objectives and delivering the best value possible to customers worldwide.  

"Clinlogix is a trusted, innovative and globally-recognized CRO with a proven history of delivering on sponsors' research requirements," noted John M. (Rob) Robertson, President and CEO of MedNet Solutions. "Our significant technical experience in medical device and biotechnology studies continues to blend well with Clinlogix' customer base. We look forward to strengthening our partnership and collaborating with them on clinical research initiatives for many years to come."

Interested in learning more about MedNet Solutions?

To learn more about iMedNet eClinical or to see a demonstration, please contact us via email at contact@mednetstudy.com or by phone at 866-258-2735.

Stay in touch with MedNet:

About MedNet Solutions
MedNet Solutions is a leading healthcare technology company specializing in electronic data solutions designed for the global life sciences community. MedNet's proven, flexible and easy-to-use cloud-based eClinical systems dramatically improve the efficiency of clinical studies and registries of all types and sizes. Beyond simply electronic data capture (EDC), MedNet's solutions deliver the tools and dashboards required to expertly manage all aspects of clinical research. Since 2001, pharmaceutical, medical device, biotechnology and Contract Research Organizations (CROs) around the world have trusted MedNet to consistently deliver the technology innovation, experience and reliability they need for success. For more information, please visit us at www.mednetstudy.com.  

Media Contact
Dirk Nelson, Director of Marketing
MedNet Solutions
110 Cheshire Lane, Suite 300
Minnetonka, MN 55305, USA
Phone: 763-258-2735
Email: contact@mednetstudy.com
Website: www.mednetstudy.com

About Clinlogix
Clinlogix is a global clinical research organization that delivers individualized clinical research solutions to the medical device and biopharmaceutical industries. Its full suite of services supports clinical development of medical devices, pharmaceuticals, biologics and diagnostics from early feasibility/discovery through first-in-human, pivotal and post-market clinical studies. The company has broad expertise addressing regional and worldwide regulatory requirements through its headquarters in Spring House, PA., and satellite offices in the UK, Germany and Latin America. Learn more at www.clinlogix.com.

Media Contact
Michael O'Gorman, Executive Vice President
Clinlogix
321 Norristown Road, Suite 100
Ambler, PA 19002-2793, USA
Phone: 215-855-9054
Email: info@clinlogix.com
Website: www.clinlogix.com

 

 


'/>"/>
SOURCE MedNet Solutions
Copyright©2015 PR Newswire.
All rights reserved


Related biology news :

1. Phase 3 study strengthens support of ibrutinib as second-line therapy for CLL
2. Study strengthens link between neonicotinoids and collapse of honey bee colonies
3. Markets Poised for Healthy 2014 as Biometrics Makes Strides in Technology Sector - Company Strengthens Board with Industrys Top Leaders
4. Hoyos Labs Strengthens Scientific Team with Two New Hires Prior to New Technology Debut at CES 2014
5. MedNet Solutions To Sponsor 14th Annual Partnerships In Clinical Trials Europe
6. CLEAR Announces Partnership with Austin-Bergstrom International Airport
7. KeyLemon Announces Partnership With Biometric Password Solution onefacein
8. handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities
9. Codonics and Omnicell Expand Partnership
10. The Sync Project Announces Partnership with Berklee College of Musics Institute for Creative Entrepreneurship
11. Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com , ... biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European Hematology ... Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase 1 ...
(Date:7/1/2020)... VENICE, Calif. (PRWEB) , ... July 01, 2020 ... ... focused on building awareness and solutions for glioblastoma—the most common and aggressive adult ... and Lisa Haile, JD, PhD. Senior Fellows are charged with supporting the organization’s ...
(Date:6/25/2020)... ... 2020 , ... eClinical Solutions LLC , a leading ... drug development, is collaborating with Karyopharm Therapeutics (Nasdaq: KPTI ) on randomized ... COVID-19. This is the first study of an XPO1 inhibitor in patients with ...
Breaking Biology News(10 mins):
(Date:7/1/2020)... ... June 30, 2020 , ... ... launch of a new clinical diagnostics immuno-oncology service, TissueInsight . TissueInsight ... , “Flagship’s TissueInsight is a service that aids pathologists, oncologists, and immunologists ...
(Date:6/28/2020)... (PRWEB) , ... June 25, 2020 , ... ... to advance photodynamic therapy for treating cancer, today announced the company has entered ... (“Roswell Park”). The agreement provides Lumeda globally exclusive rights to Roswell Park ...
(Date:6/23/2020)... ... 23, 2020 , ... DeCurtis Corporation, the premier provider of ... Fournier has been appointed CEO and President. Founder and former CEO, David DeCurtis, ... “DeCurtis Corporation has been on an incredible journey for the last twenty years, ...
(Date:6/23/2020)... (PRWEB) , ... June 23, 2020 , ... ... innovative CNS therapies, today announced that it has filed an Investigational New Drug ... Phase 2b clinical trial of its lead drug candidate NBTX-001 in patients with ...
Breaking Biology Technology: